NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $2,371,000 | -27.5% | 41,603 | +1.6% | 0.22% | -29.4% |
Q2 2018 | $3,271,000 | -9.8% | 40,967 | -2.1% | 0.31% | -10.5% |
Q1 2018 | $3,628,000 | +17.5% | 41,856 | -6.4% | 0.34% | +20.8% |
Q4 2017 | $3,088,000 | -27.6% | 44,725 | -4.8% | 0.28% | -28.0% |
Q3 2017 | $4,268,000 | +7.8% | 46,959 | -11.7% | 0.39% | +8.0% |
Q2 2017 | $3,958,000 | – | 53,175 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |